Pelikan Technologies, maker of diagnostic and health-monitoring devices that can be used by regular people, nabbed a $12.5 million tranche of an expected $25 million seventh round of funding, according to VentureWire. Its flagship product, the handheld diabetes tester Pelikan Sun, is already on the market and is even being targeted for children.
The Palo Alto, Calif.-based company has raised $145 million to date. Its most recent round amounted to $69 million last December. Contributors to recent and past investments include Bio*One Capital, Clarus Ventures, GE Finance, Global Life Science Ventures, HBM BioVentures, Mannheim Holdings and Oxford Finance Corp.